These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6441492)

  • 1. [Progressive myositis ossificans. Report of a case and results of treatment with disodium etidronate].
    Sánchez E; Maturana I; Delgado A
    An Esp Pediatr; 1984 Oct; 21(6):597-601. PubMed ID: 6441492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial fibrodysplasia ossificans progressiva: trial with etidronate disodium.
    Dua T; Kabra M; Kalra V
    Indian Pediatr; 2001 Nov; 38(11):1305-9. PubMed ID: 11721075
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrodysplasia ossificans progressiva (myositis ossificans progressiva) treatment with disodium etidronate.
    Hall JG; Schaller JG; Worsham NG; Horning MR; Staheli LT
    J Pediatr; 1979 Apr; 94(4):679-80. PubMed ID: 107305
    [No Abstract]   [Full Text] [Related]  

  • 4. Myositis ossificans progressiva: a 10-year follow-up on a patient treated with etidronate disodium.
    Bar Oz B; Boneh A
    Acta Paediatr; 1994 Dec; 83(12):1332-4. PubMed ID: 7734885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrodysplasia ossificans progressiva. A survey of forty-two cases.
    Rogers JG; Geho WB
    J Bone Joint Surg Am; 1979 Sep; 61(6A):909-14. PubMed ID: 113413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrodysplasia (myositis) ossificans progressiva treated with disodium etidronate.
    Hentzer B; Jacobsen HH; Asboe-Hansen G
    Clin Radiol; 1978 Jan; 29(1):69-75. PubMed ID: 414874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva.
    Brantus JF; Meunier PJ
    Clin Orthop Relat Res; 1998 Jan; (346):117-20. PubMed ID: 9577418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effect of etidronate disodium (EHDP) on heterotopic ossification following total hip arthroplasty.
    Yutani Y; Ohashi H; Nishimura N; Yamano Y
    Osaka City Med J; 1995 Dec; 41(2):63-73. PubMed ID: 8778647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurogenic myositis ossificans - report of two cases with a discussion on the therapeutic use of ethanehydroxydiphosphonate (EHDP)].
    Ye QB; Wang GS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():5-8. PubMed ID: 6459878
    [No Abstract]   [Full Text] [Related]  

  • 10. Use and complications of high-dose disodium etidronate therapy in fibrodysplasia ossificans progressiva.
    Rogers JG; Dorst JP; Geho WB
    J Pediatr; 1977 Dec; 91(6):1011-4. PubMed ID: 411907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis ossificans progressiva.
    Ghosh D; Srinivasan KS; Karmakar PR; Mukherjee S; Banerjee S
    J Assoc Physicians India; 1991 Feb; 39(2):216-8. PubMed ID: 1885493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myositis ossificans complicating severe Guillain-Barré syndrome.
    Hung JC; Appleton RE; Abernethy L
    Dev Med Child Neurol; 1997 Nov; 39(11):775-6. PubMed ID: 9393894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury.
    Spielman G; Gennarelli TA; Rogers CR
    Arch Phys Med Rehabil; 1983 Nov; 64(11):539-42. PubMed ID: 6416224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrodysplasia ossificans progressiva.
    Tonholo-Silva ER; Adachi EA; Tafner MS; Yoshinaga L
    Arq Neuropsiquiatr; 1994 Mar; 52(1):100-2. PubMed ID: 8002796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 3 year old girl with fibrodysplasia ossificans progressiva.
    Ali NS; Qureshi R
    J Pak Med Assoc; 1999 Sep; 49(9):223-5. PubMed ID: 10646326
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrodysplasia ossificans progressiva.
    Chopra K; Saha MM; Saluja S
    Indian Pediatr; 1987 Aug; 24(8):677-80. PubMed ID: 3127343
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrodysplasia ossificans progressiva. A case report and focus on the BMP signaling pathway.
    Bouvard B; Masson C; Legrand E; Audran M
    Morphologie; 2016 Dec; 100(331):250-255. PubMed ID: 26948676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic intoxication by ethane-1-hydroxy-1,1-diphosphonate (EHDP) in a child with myositis ossificans progressiva.
    Pazzaglia UE; Beluffi G; Ravelli A; Zatti G; Martini A
    Pediatr Radiol; 1993; 23(6):459-62. PubMed ID: 8255652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomalignant heterotopic ossification.
    Kaplan FS; Gannon FH; Hahn GV; Wollner N; Prauner R
    Clin Orthop Relat Res; 1998 Jan; (346):134-40. PubMed ID: 9577421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.
    Smith R; Russell RG; Woods CG
    J Bone Joint Surg Br; 1976 Feb; 58(1):48-57. PubMed ID: 818090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.